Haolun Shi

发表

START: single‐to‐double arm transition design for phase II clinical trials

Teng Zhang, Haolun Shi, Guosheng Yin, 2020, Pharmaceutical statistics.

Landmark cure rate models with time-dependent covariates

Haolun Shi, Guosheng Yin, G. Yin, 2017, Statistical methods in medical research.

Bayesian adaptive clinical trial designs

Haolun Shi, 石昊倫, 2018 .

Two-stage seamless transition design from open-label single-arm to randomized double-arm clinical trials

Haolun Shi, Guosheng Yin, G. Yin, 2018, Statistical methods in medical research.

Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints.

Haolun Shi, Guosheng Yin, 2018, Biometrics.

Functional principal component analysis for longitudinal data with informative dropout

Liangliang Wang, Haolun Shi, Jianghu Dong, 2020, Statistics in medicine.

uTPI: A utility‐based toxicity probability interval design for phase I/II dose‐finding trials

Jiguo Cao, Ying Yuan, Haolun Shi, 2021, Statistics in medicine.

Bayesian randomized clinical trials: From fixed to adaptive design.

Haolun Shi, Guosheng Yin, Chi Kin Lam, 2017, Contemporary clinical trials.

Control of Type I Error Rates in Bayesian Sequential Designs

Haolun Shi, Guosheng Yin, G. Yin, 2019, Bayesian Analysis.